3D Systems has reported unaudited Q4 2020 revenue of US$172.7 million, an increase of 2.6% compared to US$168.2 million in Q4 2019.
Q4 revenue in Healthcare increased 48% to US$86.6 million, driven by strong sales in both dental applications and medical applications, while industrial sales decreased 21.6% to US$86 million, compared to Q4 2019.
Full year 2020 revenue was US$557.2 million, a decrease of 12.4% from US$636.4 million in 2019. Revenue from Healthcare increased 9.1% to US$245.4 million, while industrial sales decreased 24.2% to US$311.9 million.
‘With our singular focus on additive manufacturing, we were pleased to deliver strong growth at the end of what was an unprecedented year,’ said Dr Jeffrey A. Graves, CEO.
This story uses material from 3D Systems, with editorial changes made by Materials Today. The views expressed in this article do not necessarily represent those of Elsevier.
